Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Present knowledge of immunization against tuberculosis.

Literature DB >> 798638

Present knowledge of immunization against tuberculosis.

Abstract

This is a selective review, which, after recalling some immunological aspects, analyses the present knowledge on the protective efficacy of BCG vaccination, the vaccination reactions and complications that may be observed, and current methods of vaccine production and control. As regards the application of BCG vaccination, particular attention is given to dosage and vaccination techniques, direct and simultaneous vaccination, and revaccination. Finally, the evaluation of BCG vaccination programmes is briefly discussed.

Entities: Disease

Mesh：

Substances：

Year: 1976 PMID： 798638 PMCID： PMC2366573

Source DB: PubMed Journal: Bull World Health Organ ISSN： 0042-9686 Impact factor: 9.408

22 in total

Present knowledge of immunization against tuberculosis.

1. TUBERCULOSIS IN HONG KONG.

2. ACQUIRED IMMUNITY TO TUBERCULOSIS.

3. The heterogeneity of BCG.

4. Differential characteristics in vitro and in vivo of several substrains of BCG. IV. Immunizing effectiveness.

5. The occurrence of pulmonary lesions in BCG-vaccinated and unvaccinated persons.

6. Variation in the duration of tuberculin skin sensitivity produced by two strains of BCG.

7. [Protection conferred by BCG during the twenty years following vaccination].

8. Results of B.C.G. vaccination with the bifurcated needle.

9. Combined BCG and smallpox immunization: a preliminary report on a method using the W.H.O. bifurcated needle.

10. Variability of BCG strains (Bacillus Calmette-Guérin).

1. The periodic health examination. Canadian Task Force on the Periodic Health Examination.

2. In vitro characterization of T cells from Mycobacterium w-vaccinated mice.

3. Does BCG vaccine prevent tuberculous meningitis?

4. Comment on "tuberculosis studies in Muscogee County, Georgia".

5. A case-control study to evaluate the effectiveness of mass neonatal BCG vaccination among Canadian Indians.

6. Immunogenicity and safety of early vs delayed BCG vaccination in moderately preterm (31-33 weeks) infants.

7. BCG in Britain.

8. BCG-induced changes in size of thymic cortex and thymus-dependent areas in spleen and lymph nodes of mice.

9. High-viability lyophilized Bacille Calmette-Guérin vaccine produced by deep-culture technique.

10. [Vaccination: 1982 status].